Antisense modulation of AKT-1 expression
US5958773A · kind A · utility
87Cited by
0References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 17, 1998 |
| Grant date | Sep 28, 1999 |
| Priority date | — |
| Expiry date | Dec 17, 2018 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02P20/582
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Antisense compounds, compositions and methods are provided for modulating the expression of Akt-1. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding Akt-1. Methods of using these compounds for modulation of Akt-1 expression and for treatment of diseases associated with expression of Akt-1 are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.